Archived from groups: comp.sys.ibm.pc.hardware.chips (
More info?)
On Tue, 01 Feb 2005 13:00:59 -0500, Robert Myers <rmyers1400@comcast.net>
wrote:
>On Tue, 01 Feb 2005 04:37:41 -0500, Tony Hill
><hilla_nospam_20@yahoo.ca> wrote:
>
>>On Sun, 30 Jan 2005 12:53:01 GMT, "Felger Carbon" <fmsfnf@jfoops.net>
>>wrote:
>>
>
><snip>
>
>>>
>>>Reading between the lines, I sense that you feel that nobody should
>>>have to pay royalties in order to make parts. Am I wrong on this?
>>
>>Not at all, just that people shouldn't have to pay royalties to a
>>company for something that company did little to no work at inventing
>>but just happened to have worked the patent system to their advantage.
>>I mean honestly, paying x dollars per chip for a friggin' counter?!?
>>
>>I see no problem at all in Rambus collecting royalties on their RDRAM
>>or XDR memory since it's clear that they did real and viable work to
>>develop those technologies. However their patents on SDRAM and now
>>DDR/DDR2 are much less meaningful.
>>
>>>An IP company (e.g. Rambus) would be derelict _not_ to take maximum
>>>advantage of patent legalities, since that's the only way it can make
>>>money, and the company's officers are legally required to work in
>>>their stockholders' interest, not in the larger interest of society.
>>>Corporations are not charities.
>>
>>Very true, which is why I see the primary problem here being those
>>very patent legalities. There's no way that Rambus should have been
>>able to get patents on most of what they were given patents to. The
>>technology was very obvious and in widespread use when most of these
>>patents were granted, it's only due to the web of divisions,
>>continuations, extensions and abandonment's that they were able to get
>>those patents.
>>
>
>It's fairly easy for technical people to imagine that the lawyers
>don't really grasp the technical issues at stake, and the technical
>people are probably right most of the time.
>
>Have you thought about it the other way around, though? That is to
>say, you could go on and on about the technical issues, but how well
>do you think you really understand the legal issues?
>
>The one patent case I followed through in detail was was heard en banc
>by the federal circuit court of appeals (the full appellate court
>heard the case, not just a three-judge panel). The issues at stake
>remind me somewhat of the Rambus case: the patent holder filed a
>patent on a process for which there was significant and obvious prior
>art. The patent claimant made a distinction in the patent that was
>recognized and upheld by the appellate court.
>
>Not only that, but the patent claimant made broad claims that allowed
>them to assert that a process that bore no resemblance to there patent
>was infringing by the principal of equivalence. Those broad claims
>were upheld as well. The lawyers got rich.
We're not assuming in our disgust for RMBS that lawyers are not licensed
racketeers.
This glaring example might be a good starting point for
fixing that system -- it would appear to be fixable, or am I being naive?
-- before they own us all.
>I remember the arguments made repeatedly by those involved with the
>defense: there was prior art, and, in any case, their process was
>different. It all sounded right to an engineer. Not to the lawyers,
>though.
>
>Everyday notions of reasonableness just don't cut it in the IP
>business. Either you manage to stake your claim and successfully
>defend it, or you don't.
>
>As to this principal of equivalence, which is an issue in the Rambus
>case, what is it that allows one drug company to put a different side
>chain on the same aromatic ring and patent a new drug? I have no
>idea, and I'm really clear that I don't understand patent law.
Well the medical industry is pretty much a buncha licensed drug dealers
but....
It's not so much the chemical compound they have a patent on - some of
them, or very close analogues, are found in nature after all. The
synthesis of most modern drugs involves a complex series of reaction steps
-- twenty steps is not unusual -- each of which could be "original" and can
require considerable tweaking to get useful yield.
On that subject, the Lipitor case is an example of one where things might
get "fixed":
http://www.pubpat.org/index.html so things are not completely
hopeless. Slightly more on topic, the same guys got the M$ FAT patents
thrown out... is there a glimmer of hope here?
You might also wonder how California managed to pass "emissions
regulations" which basically imposed a recipe for gasoline on the petroleum
business and a certain California-based petroleum company just somehow came
up with patented process designs for making the ingredients which satisfied
the regulations.<shrug>
--
Rgds, George Macdonald